AC
PTX

Aisling Capital’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Aisling Capital’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,000
Closed -$90K – 21
2014
Q2 		$90K Buy
+1,000
New +$61.3K 0.03% 16

Aisling Capital's PTX Position: Q1 2019 in Review

Aisling Capital sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q1 2019, closing a stake of 210,000 shares — an estimated $88K sold.

Aisling Capital first reported a position in PTX in Q2 2014 and held it in 19 quarters. The position peaked at $21.5M in Q1 2015. 1 fund tracked by Wall St. Rank holds PTX as of Q1 2019.

  • Aisling Capital reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q1 2019 after selling out during the quarter.
  • Aisling Capital sold 210,000 Pernix Therapeutics Holdings, Inc. shares in Q1 2019, an estimated $88K.
  • Aisling Capital first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2014 and held it in 19 quarters.
  • Aisling Capital's Pernix Therapeutics Holdings, Inc. position peaked at $21.5M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q1 2019.

Based on Aisling Capital's 13F filing for Q1 2019, filed 7 May 2019.